HEALTH● LOW1h ago · Oct 8, 2026, 7:26 PM
Genentech's Tecentriq gains new indication for colon cancer
Seeking Alpha Tech · global
Genentech's drug Tecentriq has received a new indication for colon cancer. This development could expand treatment options for patients with this type of cancer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoWorld Sight Day: glaucoma awareness camp for elderly held in Srikakulam onThe HinduHEALTH1h agoHHS launches NIH clinic to study vaccine injuriesThe HillHEALTH1h agoISCCM to hold critical care awareness walkathon on FridayThe HinduHEALTH2h agoTamil Nadu govt. honours 319 villages for becoming TB-free in Vellore, nearby districtsThe Hindu